GemVax&KAELLtd Beheer
Beheer criteriumcontroles 0/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Sang-Jae Kim
Algemeen directeur
n/a
Totale compensatie
Percentage CEO-salaris | n/a |
Dienstverband CEO | no data |
Eigendom CEO | 3.0% |
Management gemiddelde ambtstermijn | geen gegevens |
Gemiddelde ambtstermijn bestuur | geen gegevens |
Recente managementupdates
Recent updates
Some Confidence Is Lacking In GemVax&KAEL Co.,Ltd. (KOSDAQ:082270) As Shares Slide 28%
Nov 04GemVax&KAEL Co.,Ltd.'s (KOSDAQ:082270) 30% Share Price Surge Not Quite Adding Up
Sep 19Risks To Shareholder Returns Are Elevated At These Prices For GemVax&KAEL Co.,Ltd. (KOSDAQ:082270)
Jul 05GemVax&KAELLtd's (KOSDAQ:082270) Earnings Are Weaker Than They Seem
Apr 03Is GemVax&KAELLtd (KOSDAQ:082270) A Risky Investment?
Feb 17Investors Who Bought GemVax&KAELLtd (KOSDAQ:082270) Shares Three Years Ago Are Now Up 52%
Dec 26CEO
Sang-Jae Kim (58 yo)
no data
Tenure
Mr. Sang-Jae Kim serves as Chief Executive Officer at GemVax&KAEL Co.,Ltd. He serves as Co-Chief Executive Officer of BIOVILL Co.,Ltd. (formerly known as KSCB Co.,Ltd.) Mr. Kim serves as the Chief Executiv...